Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cystic fibrosis–related metabolic defects: crosstalk between ion channels and organs
Sunder Sims-Lucas, … , Eric S. Goetzman, Thomas R. Kleyman
Sunder Sims-Lucas, … , Eric S. Goetzman, Thomas R. Kleyman
Published July 1, 2024
Citation Information: J Clin Invest. 2024;134(13):e182329. https://doi.org/10.1172/JCI182329.
View: Text | PDF
Commentary Article has an altmetric score of 1

Cystic fibrosis–related metabolic defects: crosstalk between ion channels and organs

  • Text
  • PDF
Abstract

Cystic fibrosis is a debilitating disease characterized by a poor medical prognosis due to devastating lung injury. Recent medical advances targeting the major genetic mutation ΔF508 of the cystic fibrosis transmembrane conductance regulator (CFTR) protein have dramatically increased the lifespan of patients with this mutation. This development has led to major changes in the field and has pushed research beyond the ion transport nature of cystic fibrosis and toward multiorgan physiological reprogramming. In this issue of the JCI, Bae, Kim, and colleagues utilized a large animal pig model prior to the onset of disease. They revealed metabolic reprogramming and organ crosstalk that occurred prior to disease progression. These findings provide paradigm-shifting insight into this complex disease.

Authors

Sunder Sims-Lucas, Eric S. Goetzman, Thomas R. Kleyman

×

Figure 1

CFTR contributes to whole-body metabolite balance.

Options: View larger image (or click on image) Download as PowerPoint
CFTR contributes to whole-body metabolite balance.
(A) Bae et al. (12) s...
(A) Bae et al. (12) show that in wild-type pigs, intestine, liver, and muscle primarily secrete metabolites, while other organs such as the lung and heart primarily take up metabolites. The healthy kidney plays a key role in metabolite homeostasis, taking up amino acids (AA) and other metabolites when concentrations are high and releasing them when concentrations are low. Metabolite loss to the urine is minimized by the absorption of filtered metabolites in proximal tubular segments of the nephron. This process is maintained by numerous Na+-dependent (or H+- dependent) transporters on the apical surface of proximal tubular cells. (B) In CFTR–/– pigs, the inter-organ balance of metabolites is disturbed. The CF kidney presumably has disrupted ion balance across the tubular epithelium due to loss of the CFTR chloride transporter. Hypothetically, activation of a yet-to-be identified Na solute (solute X) cotransporter, or downregulation of the Na K-ATPase, leads to an increase in the intracellular Na+ concentration in proximal tubular segments of CF kidneys and disrupts the transport of amino acids and other metabolites. As a result, CF kidneys would have disordered metabolite homeostasis, which increases metabolite loss to the urine.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 2 X users
11 readers on Mendeley
See more details